Phase 3, Randomized, Open-Label Study to Evaluate Safety and Efficacy of Epcoritamab in Combination with R-CHOP Compared to R-CHOP in Subjects with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)

Project: Research

Project Details

Project Description

HREC Reference Number: 2022/ETH02182
SSA Reference Number: SSA/94227/MonH-2023-383331(v2)
ERM Reference Number: 94227
Monash Health Local Reference: RES-23-0000-418X
StatusActive
Effective start/end date13/07/23 → 12/07/28